Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02586987
Brief Title: A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours

First Submitted : September 21, 2015
First Submitted that Met QC Criteria : October 23, 2015
First Posted : October 27, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : November 15, 2019
Last Update Posted : November 18, 2019